Global Axillary Hyperhidrosis Drug Market By Product Type (Botulinum ToxinA, Glycopyrrolate) And By End-Users/Application (Clinic, Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985606
  • April 2021
  • Pharmaceuticals
  • 119 Pages

Report Preview

The Axillary Hyperhidrosis Drug market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Axillary Hyperhidrosis Drug market research report recommends a business strategy for present market participants to strengthen their position in the market.

According to the report, the Axillary Hyperhidrosis Drug market size was USD xx million and it is expected to reach USD xx million by the end of 2028, with a CAGR of xx% during 2020-2028. While considering the volume shipments the global Axillary Hyperhidrosis Drug market stood at xx (Units/Tons) in 2020 and expected to cross near about xx (units/Tons) by the end of forecast period.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Axillary Hyperhidrosis Drug market along with their effects over the forecast period. Similarly, according to the region Axillary Hyperhidrosis Drug market research report includes the study of opportunities available in the market situation.

The Axillary Hyperhidrosis Drug market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type Botulinum ToxinA, Glycopyrrolate, Glycopyrronium Tosylate, Others
Applications Clinic, Hospital, Home Care
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Allergan Plc, Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, GlaxoSmithKline Plc, TheraVida Inc

Global Axillary Hyperhidrosis Drug Market Segmentation by Regions:
In regional analysis, Axillary Hyperhidrosis Drug market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Axillary Hyperhidrosis Drug market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Axillary Hyperhidrosis Drug Market: Value and Forecast
  • U.S.
  • Canada
 
Europe Region for Axillary Hyperhidrosis Drug Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 
Asia Pacific Region for Axillary Hyperhidrosis Drug Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 
Latin America Region for Axillary Hyperhidrosis Drug Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 
Middle East and Africa for Axillary Hyperhidrosis Drug Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa



Global Axillary Hyperhidrosis Drug Market Segmentation by Type:
On the basis of product type, global Axillary Hyperhidrosis Drug market research report provides the production, revenue, price, and market share and growth rate of each type, primarily split into: Botulinum ToxinA, Glycopyrrolate, Glycopyrronium Tosylate, Others

Global Axillary Hyperhidrosis Drug Market Segmentation by Applications:
On the basis of the end users/applications, Axillary Hyperhidrosis Drug research report analyze the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Clinic, Hospital, Home Care

Major Key Players for Global Axillary Hyperhidrosis Drug Market:
The Axillary Hyperhidrosis Drug market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Allergan Plc, Brickell Biotech Inc, Dermira Inc, Dr. August Wolff GmbH & Co KG Arzneimittle, GlaxoSmithKline Plc, TheraVida Inc

Important Points Covered by Report:
  • To analyze the value of the Axillary Hyperhidrosis Drug market, according to the key region.
  • To study the Axillary Hyperhidrosis Drug market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Axillary Hyperhidrosis Drug market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Axillary Hyperhidrosis Drug research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Axillary Hyperhidrosis Drug market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Axillary Hyperhidrosis Drug market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Axillary Hyperhidrosis Drug market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Axillary Hyperhidrosis Drug market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Axillary Hyperhidrosis Drug market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Axillary Hyperhidrosis Drug Market Snapshot
          2.1.1. Global Axillary Hyperhidrosis Drug Market By Type,2019
               2.1.1.1.Botulinum ToxinA
               2.1.1.2.Glycopyrrolate
               2.1.1.3.Glycopyrronium Tosylate
               2.1.1.4.Others
          2.1.2. Global Axillary Hyperhidrosis Drug Market By Application,2019
               2.1.2.1.Clinic
               2.1.2.2.Hospital
               2.1.2.3.Home Care
          2.1.3. Global Axillary Hyperhidrosis Drug Market By End-use,2019
          2.1.4. Global Axillary Hyperhidrosis Drug Market By Geography,2019

3. Global Axillary Hyperhidrosis Drug Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028

5. Global Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028

6. Global Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028

7. Global Axillary Hyperhidrosis Drug Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Axillary Hyperhidrosis Drug Market Analysis, 2018 – 2028 
          7.2.1. North America Axillary Hyperhidrosis Drug Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Axillary Hyperhidrosis Drug Market Analysis, 2018 – 2028 
          7.3.1.  Europe Axillary Hyperhidrosis Drug Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Axillary Hyperhidrosis Drug Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Axillary Hyperhidrosis Drug Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Axillary Hyperhidrosis Drug Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Axillary Hyperhidrosis Drug Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Axillary Hyperhidrosis Drug Market Analysis, 2018 – 2028 
          7.6.1.  MEA Axillary Hyperhidrosis Drug Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Axillary Hyperhidrosis Drug Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Axillary Hyperhidrosis Drug Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Axillary Hyperhidrosis Drug Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Axillary Hyperhidrosis Drug Providers
        8.4.1 Allergan Plc
                8.1.1 Business Description
                8.1.2 Allergan Plc Geographic Operations
                8.1.3 Allergan Plc Financial Information
                8.1.4 Allergan Plc Product Positions/Portfolio
                8.1.5 Allergan Plc Key Developments
        8.4.2 Brickell Biotech Inc
                8.2.1 Business Description
                8.2.2 Brickell Biotech Inc Geographic Operations
                8.2.3 Brickell Biotech Inc Financial Information
                8.2.4 Brickell Biotech Inc Product Positions/Portfolio
                8.2.5 Brickell Biotech Inc Key Developments
        8.4.3 Dermira Inc
                8.3.1 Business Description
                8.3.2 Dermira Inc Geographic Operations
                8.3.3 Dermira Inc Financial Information
                8.3.4 Dermira Inc Product Positions/Portfolio
                8.3.5 Dermira Inc Key Developments
        8.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle
                8.4.1 Business Description
                8.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Geographic Operations
                8.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Financial Information
                8.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Product Positions/Portfolio
                8.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Key Developments
        8.4.5 GlaxoSmithKline Plc
                8.5.1 Business Description
                8.5.2 GlaxoSmithKline Plc Geographic Operations
                8.5.3 GlaxoSmithKline Plc Financial Information
                8.5.4 GlaxoSmithKline Plc Product Positions/Portfolio
                8.5.5 GlaxoSmithKline Plc Key Developments
        8.4.6 TheraVida Inc
                8.6.1 Business Description
                8.6.2 TheraVida Inc Geographic Operations
                8.6.3 TheraVida Inc Financial Information
                8.6.4 TheraVida Inc Product Positions/Portfolio
                8.6.5 TheraVida Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Axillary Hyperhidrosis Drug Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Axillary Hyperhidrosis Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Axillary Hyperhidrosis Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Axillary Hyperhidrosis Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Axillary Hyperhidrosis Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Axillary Hyperhidrosis Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Axillary Hyperhidrosis Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Axillary Hyperhidrosis Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Axillary Hyperhidrosis Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Axillary Hyperhidrosis Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Axillary Hyperhidrosis Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Axillary Hyperhidrosis Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Axillary Hyperhidrosis Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Axillary Hyperhidrosis Drug Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Axillary Hyperhidrosis Drug Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Axillary Hyperhidrosis Drug Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Axillary Hyperhidrosis Drug: Market Segmentation 
FIG. 2 Global Axillary Hyperhidrosis Drug Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Axillary Hyperhidrosis Drug Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Axillary Hyperhidrosis Drug Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Axillary Hyperhidrosis Drug Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Axillary Hyperhidrosis Drug Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Axillary Hyperhidrosis Drug Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Axillary Hyperhidrosis Drug Providers, 2019
FIG. 11 Global Axillary Hyperhidrosis Drug Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Axillary Hyperhidrosis Drug Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Axillary Hyperhidrosis Drug Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Axillary Hyperhidrosis Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Axillary Hyperhidrosis Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Axillary Hyperhidrosis Drug Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Axillary Hyperhidrosis Drug Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Axillary Hyperhidrosis Drug Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Axillary Hyperhidrosis Drug market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Axillary Hyperhidrosis Drug Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Axillary Hyperhidrosis Drug Market Value, By Segment1, 2018 – 2028
TABLE  North America Axillary Hyperhidrosis Drug Market Value, By Segment2, 2018 – 2028
TABLE  North America Axillary Hyperhidrosis Drug Market Value, By Country, 2018 – 2028
TABLE  Europe Axillary Hyperhidrosis Drug Market Value, By Segment1, 2018 – 2028
TABLE  Europe Axillary Hyperhidrosis Drug Market Value, By Segment2, 2018 – 2028
TABLE  Europe Axillary Hyperhidrosis Drug Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Axillary Hyperhidrosis Drug Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Axillary Hyperhidrosis Drug Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Axillary Hyperhidrosis Drug Market Value, By Country, 2018 – 2028
TABLE  Latin America Axillary Hyperhidrosis Drug Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Axillary Hyperhidrosis Drug Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Axillary Hyperhidrosis Drug Market Value, By Country, 2018 – 2028
TABLE  MEA Axillary Hyperhidrosis Drug Market Value, By Segment1, 2018 – 2028
TABLE  MEA Axillary Hyperhidrosis Drug Market Value, By Segment2, 2018 – 2028
TABLE  MEA Axillary Hyperhidrosis Drug Market Value, By Country, 2018 – 2028
TABLE  Allergan Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Brickell Biotech Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dermira Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Dr. August Wolff GmbH & Co KG Arzneimittle: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  GlaxoSmithKline Plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  TheraVida Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Axillary Hyperhidrosis Drug Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Axillary Hyperhidrosis Drug Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Axillary Hyperhidrosis Drug Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Axillary Hyperhidrosis Drug Market, By Geography, 2019 (US$ Mn)
FIG.  Global Axillary Hyperhidrosis Drug Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Axillary Hyperhidrosis Drug Providers, 2016
FIG.  Global Axillary Hyperhidrosis Drug Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Botulinum ToxinA Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glycopyrrolate Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Glycopyrronium Tosylate Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Axillary Hyperhidrosis Drug Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Clinic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Hospital Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Home Care Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Axillary Hyperhidrosis Drug Market Value, 2018 – 2028, (US$ Mn)